intravitreal injection of KH902

BIOLOGICAL2 trials

Sponsors

Chengdu Kanghong Biotech Co., Ltd.

Conditions

Neovascular Age-related Macular Degeneration

Phase 1

A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMD

CompletedNCT01242254

Chengdu Kanghong Biotech Co., Ltd.Neovascular Age-related Macular Degeneration

Start: 2009-08-31End: 2011-02-28Updated: 2014-03-27

Phase 2

A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMD

CompletedNCT01157715

Chengdu Kanghong Biotech Co., Ltd.Neovascular Age-related Macular Degeneration

Start: 2010-05-31End: 2012-07-31Updated: 2014-11-06